🇺🇸 FDA
Patent

US 11858913

Bicyclic pyridazinones and methods of use thereof

granted A61PA61P1/16A61P5/16

Quick answer

US patent 11858913 (Bicyclic pyridazinones and methods of use thereof) held by Aligos Therapeutics, Inc. expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aligos Therapeutics, Inc.
Grant date
Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P1/16, A61P5/16